<SEC-DOCUMENT>0000105770-14-000055.txt : 20141002
<SEC-HEADER>0000105770-14-000055.hdr.sgml : 20141002
<ACCEPTANCE-DATETIME>20141002105947
ACCESSION NUMBER:		0000105770-14-000055
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20141002
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141002
DATE AS OF CHANGE:		20141002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		141135137

	BUSINESS ADDRESS:	
		STREET 1:		101 GORDON DR
		STREET 2:		P O BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		101 GORDON DRIVE
		STREET 2:		PO BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8koct22014.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>Form 8K Oct 2 2014</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s3CD99421696BC99C7F87D105088D35AE"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:4px double #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date of Report (Date of Earliest Event Reported) &#8211; October 2, 2014 </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><img src="westlogo1022014.jpg" style="height:101px;width:252px;"></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="33.0078125%"></td><td width="3.90625%"></td><td width="27.1484375%"></td><td width="3.90625%"></td><td width="32.03125%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pennsylvania</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1-8036</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23-1210010</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of Incorporation)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">530 Herman O. West Drive, Exton, PA</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19341-0645</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;Registrant&#8217;s telephone number, including area code: </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">610-594-2900</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not Applicable</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former name or address, if changed since last report)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="4.8828125%"></td><td width="95.1171875%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td width="100%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sD1143A7086FA250EFCE9D10508AD6A54"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01 Regulation FD Disclosure.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 2, 2014, the Company issued a press release announcing plans for a new pharmaceutical component manufacturing plant in Ireland. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (Exchange Act) or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;Item 9.01 Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85.15625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="10.321100917431195%"></td><td width="14.449541284403669%"></td><td width="75.22935779816514%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated October 2, 2014.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s45344A93D913994108A2D10508EB808E"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="44.53125%"></td><td width="40.8203125%"></td><td width="14.6484375%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WEST PHARMACEUTICAL SERVICES, INC.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ John R. Gailey III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">John R. Gailey III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and General Counsel</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 2, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="sE775C6E3FCEA72C91CEDD105090AC713"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="12.00787401574803%"></td><td width="87.99212598425197%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">West Pharmaceutical Services, Inc. Press Release, dated October 2, 2014.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh991pressreleaseoct22014.htm
<DESCRIPTION>EXHIBIT 99.1 PRESS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2014 Workiva -->
		<title>Exh 99.1 Press Release Oct 2 2014</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s4B974532E05E30B85119D105069A0EDC"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;"><img src="exh991logo1022014.jpg" style="height:48px;width:276px;"></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:89.58333333333334%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="55.81395348837209%"></td><td width="44.18604651162791%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Contacts:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">West Inquiries:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IDA Inquiries:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Emily Denney</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Kevin Sammon</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">West Global Communications</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IDA Ireland</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">+ 1-610-594-3035</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">+ 353876188564</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">Emily.Denney@westpharma.com</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">kevin.sammon@ida.ie</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">West Announces Plans for a New Pharmaceutical Component </font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Manufacturing Plant in Ireland</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Expands global capabilities to meet customer demand</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Waterford, Ireland- October 2, 2014 -</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">West Pharmaceutical Services, Inc.</font><font style="font-family:inherit;font-size:11pt;">&#32;(NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today it plans to expand its global manufacturing operations to include a new site in Waterford, Ireland. The new facility will produce packaging components for insulin injector cartridges and other high-value packaging components, in order to meet growing demand from pharmaceutical and biotech customers. Once operational, this new site could bring approximately 150 new jobs to Waterford and is intended to grow to support additional jobs through future expansions.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;With diabetes emerging as one of the fastest growing diseases globally, our pharmaceutical customers are expanding their production lines for injectable insulin.  To meet this growing demand, we are announcing an expansion today that will help us address this need and continue to serve this critical patient population,&#8221; said Donald E. Morel, Jr., West&#8217;s Chairman and Chief Executive Officer. &#8220;In the future, we intend for this site to be a center of excellence for advanced packaging components to meet the needs of our customer base for a range of sophisticated injectable therapies.&#8221;   </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;Waterford, Ireland, is an ideal setting for this new plant, given its business-friendly environment and the growing health science industry in the area,&#8221; Morel added.  &#8220;On behalf of West&#8217;s Board of Directors, I would like to thank the many representatives of Waterford City, the Irish Government and the Irish Development Agency for their support.&#8221; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Construction is planned to begin in early 2015 on the 44-acre site at Knockhouse on Old Kilmeaden Road in Waterford, subject to the project obtaining requisite planning and zoning approvals, which the Company believes will occur later this year.  This site will be a center of excellence for West&#8217;s proprietary elastomeric sheeting, which is used to package insulin for use in pen injectors. Future plans include additional manufacturing space for West&#8217;s proprietary injectable component product lines, which are integral to many injectable and dosage forms.  With these expansions, the plant eventually could accommodate between 250 to 300 jobs and involve an investment in the range of &#8364;100 million.</font></div><br><div></div><hr style="page-break-after:always"><a name="s4B974532E05E30B85119D105069A0EDC"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">An Taoiseach Enda Kenny TD said, &#8220;I am delighted with this announcement of a new manufacturing facility in the South East by West Pharmaceutical Services which will create 100 construction jobs during its development and an initial 150 new jobs when operational. It is a massive boost for Waterford and the entire South East and I am happy that Government was able to assist through the work of the IDA. The Government is determined to secure economic recovery by incentivising job creation and further investment in the area. &#160;Today's announcement continues our strong track record on attracting employers in the medical devices sector and we will continue to prioritise Government support for sectors with real growth potential through our Action Plan for Jobs.&#8221;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Minister for Jobs, Enterprise and Innovation, Richard Bruton TD said, &#8220;The South East has been a key focus of my Department and Agencies since shortly after I took office. We have put in place structures like the South East Forum to bring a greater focus to this region. In the past two years the number of site visits has been well over twice what it was before 2011, we have seen many substantial jobs announcements and employment in the region has increased by well over 10,000 in the past two years. Today&#8217;s announcement by West, a world leading supplier to the pharmaceutical industry, that it is establishing a new operation in Waterford with the creation of up to 300 jobs, is another great boost. I commend the IDA for their work on this, and look forward to further announcements for the South East in the coming months.&#8221;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Martin Shanahan, CEO at IDA Ireland said, &#8220;West Pharmaceutical Services is a leading manufacturer of pharmaceutical packaging and delivery systems, including medical devices.  Ireland has succeeded in attracting over 250 medical device manufacturers employing over 25,000 people in locations across the country. The IDA and its local stakeholders have fought off stiff competition to have this plant located in Ireland. This project is a vote of confidence in the people of Waterford.&#8221;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">West has had a presence in Ireland since 2005&#160;with a manufacturing and development center in Dublin, which is the European headquarters for The Tech Group, a West subsidiary which specializes in providing device design, development and manufacturing services for pharmaceutical and med-tech customers. Employing&#160;over 230&#160;people at its Mulhuddart, Dublin facility, it is also undergoing an expansion as a result of securing a number of significant customer programs.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">About West </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pennsylvania, West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Established in 1923, West had 2013 sales totaling $1.4 billion.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">&#32;2</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><a name="s4B974532E05E30B85119D105069A0EDC"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">West and the diamond logo and By your side for a healthier world&#8482; are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">This press release contains forward-looking statements within the meaning of the federal securities laws which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; or &#8220;potential&#8221; or the negative of these words and phrases or similar words or phrases, which are predictions of or indicate future events or trends and which do not relate solely to historical matters. Examples of these forward-looking statements include (but are not limited to) West&#8217;s statements with respect to planned expansions and job creation. While forward-looking statements reflect West&#8217;s good faith beliefs, assumptions and expectations, they are not guarantees of future performance. Furthermore, except as required by law, West disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions, new information or other changes. Known material risks, uncertainties and other factors that can affect future results are discussed or incorporated by reference in periodic reports under the Securities Exchange Act of 1934, as amended, filed by West from time to time with the Securities and Exchange Commission.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">###</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">- </font><font style="font-family:inherit;font-size:10pt;">&#32;3</font><font style="font-family:inherit;font-size:10pt;">&#32;-</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exh991logo1022014.jpg
<TEXT>
begin 644 exh991logo1022014.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0`Z17AI9@``34T`*@````@``U$0``$`
M```!`0```%$1``0````!`````%$2``0````!``````````#_VP!#``(!`0(!
M`0("`@("`@("`P4#`P,#`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,
M#`P,!PD.#PT,#@L,#`S_VP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!0
M`<T#`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+
M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"
M!`0#!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`5
M8G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F
M9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:W
MN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!
M``(1`Q$`/P#]_**^0OVL_P#@M?\`"#]C+XY:E\/O%MAXXGUW2K>WN9GTS2%N
M+;;-&)$`<R+D[2,C'%>9:C_P<N_L]Z=8S3G2/BE*(D+[(_#REWP/N@>=R3T`
M]:[J>48VI!5(4FT]4['-+&4(MQE)71^A5%8_C_QUIGPQ\#ZSXDUJY2RT;P_8
M3ZGJ%RY^6WMX8VDD<^RHK'\*^$(/^#E;]GR>&-_[)^**;U#;7\/*&7(S@CSN
M#6&%P&(Q";H0<K;V+JXBG3M[1VN?H/17SK^PC_P4Y^'?_!1#4_%MKX#L_%-L
M_@N*RFU`ZQIZV@87;7(B\O#MN.;67/3'R^M1?MS_`/!4CX9?\$]]<\,:;XZ3
MQ%=7_BN"ZN;2#1K);QX8H&B1GE!=2@9I@%/.XH_]TTE@<0ZWU90?/VZ[7_+4
M/K%/V?M>;W>Y]'T5^?$O_!RO^SS#$\CZ;\342-2S,V@(`H'))_?=*^X_@]\3
M+;XS_"OP[XMLK#5-,L?$NG0:G;6NI0""[ABF0.@ECR=C[6!*DY&<'FGB<!B,
M.DZ\'&_<*6(IU':#N=)1117(;!1110`4444`%%%</^T'^T=X+_97^',OBWQ[
MKMMX=\.P7$-H]Y.CNHEE<)&F$!8EF('2JC&4I*,5=L3:2NSN**^5O^'V/[,'
M_15M)_\``.Z_^-5[%^S;^UI\/_VN_#.H:S\._$,/B72]+N_L-S<PP2Q)'-L5
M]G[Q5R=K*>/45O4P6(IQYZD&EW:9G"O3D[1DF_4]'HHHKF-0KQ3]NS]LFQ_8
MM^#,OB$Z#K7B_P`0WS-:Z%X?TFTFN+K5;K;NP?*1S'"H^9Y2N%&`,LRJ=?\`
M:[_:X\+?L=_":Y\2^([VP6YE+6VDZ;/J$-E)K-WL++;QO,P1<@$LQ.%4$G/0
M_A5\<XOC#^VG\<M5\<>(_BE\+=/U;52(X+6#XF65A9Z5:J28K2$"8?NTW'YF
M^9V+,W)KW,FRE8J?M*SY8+OU\E^K.'&XMTERTU>3_#S/JK_@D=^V!\=M+_;L
MUQOC%X9^)!T;XW,JM?7_`(8U&RTS2-2@5OLWDB2/9#;M%NM\!NJVY9F(+']?
M0^%&03QZ5_-'XT_8O\;^!K&'6+CXH?"II(YT:"YL?B?97EQ;SJ=\;*JRD[@5
MW`\C*\^_ZU^$?$?B/_@I+^S;\,_&-G_8/B6_T9X[#Q3I-AJ\7V6+5;>1#,=_
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M``G_`&_;;4%\`:Q=-JNDQ)<7FDZE;&TOH87.U9@A)#Q[N-Z%@"0"1D9[:F6X
MJ%+V\J;4>]M-3".)I2G[-25^Q[]1117$;A1110`4444`%%%%`!112,V,>YQ0
M`M%?-W_!-C]O76OV^OAWK^O:W\*/%WPEGT6]ALTL-?299;P/`DID3S8(254L
M4.`1E3SVK=_X*!?\%`?!O_!.#X,Z?XY\<:?XBU+2-1U4:/'%HMM'<7"S&UN;
MG<5=T&S9:R#.<Y*\<Y'2\'65;ZORWGM96?Y:&7MH<GM+Z'NE%4O#>NQ>*/#U
MCJ4"R)!J%O'<QAQA@KJ&&1ZX/-7:YVK.S-0HHHI`%%%%`!1110`4444`%%%%
M`!1110!_.W_P6WU)M6_X*@?$S><_9C80#Z+90X_G7A?[+O@D_$K]J?X6^'U4
M;=6\8Z-"X(R"@OH9'!'H41@?K7JO_!7'5SK7_!2_XP2G_ECK"6W_`'[MX5_I
M3_\`@D#X1'C/_@I?\(X-J[;+5)-18,.#Y-M-(/U`K]?HS]EEBGVII_\`DI\9
M.//BG'O+]3]4O^#A?]H>+X1?L$W/A>"94U;XFZE%H<2!L.;9/](N6'MLC"'_
M`*Z@=Z_!Y4!49%?=W_!P[^T-_P`+=_;GL_"-M,\FE_"[1UL/+SE1?796XNG'
M_;-+-.>\3>M?#5YI=SID%C)<0M%'J-L+NV)/^MB+N@<>VZ-Q_P`!KEX;PGU?
M`QYMY>]]^WX6-,TK>TQ#MLM/Z^9^L7_!K;X6:'0_CIXB.?+N]0T;1@>VZVM[
MFX/XXOU_2OD[_@N3\>Q\=/\`@HYXLM8)?-T[P%!!X8ML/N4/$OG7!';_`%TS
M*?=,'IQ]E_\`!OAXRT_X$?\`!-[XS>/]7/EZ7I'B?4=;NCD+F*TTFS#`$]\1
M8%?D'K?B:_\`&FOZAKNK,TNKZ]>SZG?NQ^9[BXE::5C[EW8FN;+Z'M,VQ&(E
M]FT5ZV7Z+\3;$U.7!TZ7?4],_8;_`&;#^UY^UYX"^';PO+INNZDLFK[?X=/@
M!FN<^@:-"GUD%?T[6L:PVZ(B+&B#:JJ,*H'0`>F*_&+_`((*:)X:_9H^$7Q@
M_:9^(-S'I/AO1(U\,Z9<R(6DD"[)KHQ+CYVDE>U@15.XO%(,8()\B_;!_P""
MZWQK_:7UV>'PAJ=W\)O"`<BVL-(F0ZI.G(#7-WC(<@Y*0[54\;GQO/!G&#Q&
M:8UTJ.D*>C;VN]7\]E\M3HP5:GA*'/4^*6MO(_?LRD-C:V/6G*VX9Y'UK^4O
M5_CAXK\1ZYC4O'?BR_U%OWA%QXBNI)B/[V#+G'O7H_P*_P""A7QO_9JUZ"_\
M)_$OQ2L<#[FT_5;V35--N1W22"9F&#CDH4;T85SSX+K*/N5$WZ6_'4UCG<&_
M>B[>I_3=17BO[$G[9FC_`+7_`.R1H'Q2\F#P_!>6TS:O;S7*F+29[=F2Y5I3
M@>6I1F#L!\A4D#D5^57[??\`P<`^/?C+XIO]!^"M[)X&\%V<SP1:_'&DFKZZ
MH/\`KD\Q2MK"V,JH!D888LF=@^?P638G$UI4(*SCNWLCT:^-I4H*I)[[>9^W
MID(8C:<#O2H^X="/J*_E1\9_M%>-?%>KK-XA^(OC'4;ZY/R-?^)+IY)3Z*&D
MY_`5TOPQ_;#^+_P8U%+OPG\4?'NBR(0=BZS-<0MCLT,Q>)A[%3UKZ"7!=51N
MJJOZ.W]?(\U9W&_P:>I_457Y:?\`!T#\4CI_PB^$_@:)P&US7[K7[@!B"8K*
MV\E5(Z$&2^1N>\0QT-:?PO\`^"R6N?'#_@DC\9O&>H&W\/?%/X=68T26YL&6
M)+NYO$2.ROX$.=A9G?*<XDMY-ORXQ^2GQ>^/?CS]H76+&_\`'WC'7_&5]I<#
M6UI<:K<":2WB9@S(I`&`6`)^E+(,BK1Q?MJUDJ;LUW=M+?>F5F./@Z/)#[2_
M4Y1U&..">F*_?W_@@-\*S\-_^":OA.^E7;<>,[R]\0,"FT^7+.T</US%%&P/
MHPK\`I$WKT&:_2G_`(-]OC7\5OB_^UPGA?5/'OBV_P#AYX`\'3W"Z-).K:;;
MDRV]K96Y0`;1M:X=.3_QZD>X][B?#SJX%\K247=WZVTM^)YN4U(PKV:U>A^T
MM>9_M:_M:^"_V*_@S?>./'6H/9Z3;.MO!!`HDN]2N7#%+:WC)'F2L%8@9``5
MF)"J2+_[2O[2?A']DSX-:SXZ\;:D--T+1XMS;0&GNY6XCMX4R/,F=OE51U/7
M`!(_`W]L?_@I7IO[=/Q6C\3?$+X;ZI?6>E+);Z'I,'CJ6RMM(MW(+85;1P9I
M`D?FR`_,4`&%4`?#Y/D]3&SYG%\BW:M]RNU_P#W\;C8T%:_O/;^D1?M4_'SP
MS^WW\<KCQO\`$;XSZSHLBHUKI6F6GPXN+ZUT&S+!A;PG^T$+$E5,DF%,C*"0
M`$5<+P]\`?V;[]U&H?M+>*H`>I3X2W$./Q-[+6+IW[27[.&B1H-3_9^U*Y9.
M&:3XQW$(_P"^?L`_G78>#_VU/V-+"91J_P"S3K%R@QGR/BBUXWY.8/YU^AJG
M5I04*4*D8K9+V5CYN4H3DY3E%M_XSJ_"G[)_[%UU(K:C^U1XY4_Q"/P9]D'X
M;K>0C\S7L7_!&3]HWP%^QS^VAJGP\TGXH:EXU\+_`!*N5TF*>7PA_9%D^HQ,
M1:7D4S7LS;)8S)$5,:EB\)^785;C/"7[;7[`.I/'Y'[)?Q&N).XAN8-04?@-
M38G\J\S_`&V?BS^S[KWBO0]4^&?P"\=^!+2ZL`-^HWUWX8>&ZAE)6>U6-94E
M90T9,JN"K*F1T)\^I2J8E2PU95+27VO9V36STLSH4H4FJL''3MS']%B_='TI
M:\!_X)J?MIVG[>'[*FA^-MD%IKL);3-?LHGW"SOX<"0#@$*ZE)%X'RR"O?J_
M-JU&=*HZ516DG9GT].:G%2CLPKR7XD?\G4_#_P#Z]+W_`-`->M5Y+\2/^3J?
MA_\`]>E[_P"@&M,+_$?^&7Y,\[-_X,?\=/\`]+B>L0?ZI:=38/\`5+3JYSU#
M\0?VB/VJ=%_8M_X+Z>.OB%X@TC5M=TK2X6M9;+38XWN)#/I<,:D"1E7:#R<G
MI5C_`()4Z!J/[7'[9W[0OQ?^&E]X?^&>JW?A;5H/#7ANPO(9+VVN;]K8PR^4
MRB,VRR6@:1L!//F0#`3YCXP?M=^"?V,/^#AKQKX[\;ZC+;:'I,+VUPMHHGN0
M\VEPI&!'N!(S^5;'_!,?Q1'^VW_P7`\3_&SX:^&;S1_AK9I>S7UT8UBB'FV2
M6RI(8LQ?:+B<+<&$,2%C+O\`,.?T2NG'!NHH\O[J/O/9VM[MMKON?-TW>MRW
MO[[TZ^IT'PX_X+#>.M5_X(?>+OB#?>+7;XI:=XFB\-V6KM:Q++_I)ANHI/+V
M",LMH\O&WI&<\U^D7["<OC&\_8W^'%Y\0M7GUWQIJNAV^I:Q=3PI%(9KA?/,
M15%51Y8D$?`Z1\Y/-?BO^TS^S3J=K_P5"\3?LY6H%KX0^)7Q4T_Q68$4J$CG
M2XE8K_LK#=W0^L:^F*_?^T@C@MUCC1(XD`5$4855`P`!V&*\#/J="G3A[&*7
MM&Y^B:5EZ;Z'HY?*I*3YV_=]WYK=_D?FS^R%^WY\0OA5^UE^UC\//BWXGN_%
M-K\+-+O?%'AV:[MX+>2*PM'ED*8C52Y>"XL3WP4;^]7SM;_\%:_CU\*O^"8^
ME>,]4\5G7/B%\5_&=SH^B7EWI\`30]-L[8&YEA555'D:Y:.)?,!"B1FYV8,_
M_!P]X1U']G?]KR#QQHD0CM?B_P"!;SP]J("X^U/`\23+Q_$8GM,>Z9YQ5C_@
ML'^R!J'[-_\`P2R_9B%M:22Z?\,W^S>))$!_T>[U"W6YFNG)XCC>\BD3)(`>
MYB'`/'KX;#X2?L:DH1_>N.EE]F+O]\K7[G'4J5E[2*;]Q/\`%JWW*YW]K^TA
M^U%_P3;_`&W/A'X.^,GQ#TCXG^&?BO<);30PP`FR#W$5N[1.8XW62*2>$CJC
MHS#:IY7U'_@G/^V3\3?C1_P5M_:'^'?B?Q5<:MX+\'/J@T;3'MH42Q$.J1P1
MX94#MB-BOS$]?6OG+]L3]KWP;_P5%_X*7?LN6/P>EU37IO#UZ+G4?.L7@-M&
M;VSN9692-P6&*U<R/C8"Z`,2:B_9-_:G\'?L2?\`!:[]J#4OB#>7FG2:M>ZG
M8:786MG)=WVK7=QJ-O<VUK!#&"SRSQ.C1KP&SU%14P2J8=N=)*JZ;;2C9WY[
M)V6VG8J%=QJJT_<YM[_W>_J5_@+_`,%.OCOXN_X)-?&OXA:C\0KZY\9^%_&F
M@:9I>IFQM0]I;7`T_P`Z,((]A#>=)RRDC=P>E?9W_!*36/VD_C"^C?%#XL>*
M-`U#X>>+O`NGG0-)L6`N8[D>7F^N5$2CSKB,-*VURJF78%4#%?EG^S/JEI!_
MP0Q_:-<W=F8H?B+X81Y1,A0'&EC!;.*_;#_@EC+'<_\`!-SX$O&Z2(W@31RK
M*P96'V2/D$5AGE.G0HU%3A%7FU>RT7+%Z=OZ[LTP4I3G#GD_A3W\V>"_\%UO
MVY/'_P"R-X/^&>A>`=8L?"%S\0]5GM+[Q-=0B9=(@A$.0`58+GS_`#&?:S".
MW?:I)RNI_P`$ZF_:G\%_':^\/?$KQ%X9^,'P=U#2$U'2/']E<0*TD[[3&D(0
M[I8V'F!PP.TB-ED*LRT__@M;^T9X.^"OPY\%Z/\`%CX12?$+X3>+M:2UUC6Q
MJ/V;_A%)U(\J:-50R&X*-,8RLD6=KIORP5OD3_@D7XRT;X?_`/!6C5/A_P#L
M\^,_$?C#X%ZAHL^JZM9Z@KB#3CY:E9B&48D6X,<:R;$:19I%8/LWCFPV&Y\K
M;C!*R;YFDT[/I).\9+9)Z,TJU>7%).3Z:)[?+JO/H;7[#/\`P53^,6H?\$F?
MCE\5?%/B7_A*_&?AB[T^QT*YOK.%8[.2ZM[9`Y2-5#A9)S)ANI`!XXKY[_X*
M(7/Q]\<_\$A/`/Q#^*GQ&T_QOX2^(NNC5=,TZYTP0:MH<YTW5?L[BXC(CE@G
MMO,=HVC5HV,(4D!\Q_L!Z3+XX_X((_M*C22FHMIFIZ-J,ZV["4I#;P6,TK';
MGA8T=CZ!2>U5/VY/VV/A_P#&/_@A3\%_AIHFL"Y\8?#5[7_A([41/Y.E0V^F
MZE812RSX\I?M+R1-"NXLZLV!E'"_14<-&GC&Z%-?Q4G[JT7*K>FO:W8\R=24
MJ-IR?P7WW=_Q/L7]N?\`;M^*$G[2WPP_9^^&WCWPW\(K*?PQ9:AK7BS5C$B1
M,]H\H4R2_*D:QQ8"KAI))5&Y0.>J_P""3_[>?Q.\0_ML>//V>_B5XP\._%,>
M'='EUK1O&6D/$T=W'"]D'3?$-DB.E]$1GYHY(94+.""/FC_@HKX)\!>"O^"G
MOPGU[X[:=<O\&O&W@ZPADN8_-5)GAL98L!XR&+13M;NRH2VQPV"*]K_X(Z:_
M\"_'G[?_`(_7X$?!J\T?PSX+T&YT\?$"3Q3>727JSSV3"U-A+%MA:9HI)%)E
M+A+0,5'FX'DXC#T(Y?=4[KDO>RLI7WYKWOTY==.AV4JDWB.7FL[VM=[6[;6\
MS]4%.Y0?6EI%X49I:^*/<"BBB@`HHHH`****`"BBB@`HHHH`_F=_X*4:F-8_
MX*'_`!JG!R!XMO(O^^"J?^RUZS_P0OU72O!/[<M_XQUR>.UT3X?>!M;\3:A,
MREC%;PBWBD95'+,/M(P!R<\5X+^VMJ0U7]MCXS7(Y$GCC6<'.?NWLJ_TJ7X+
M>/XOA=^SM\9KX!AK/C.#1O`FELIP5M[B>YU#4V_W!%IME&?]JYB!QN&?V"K1
MY\`J*ZQC'[[)_<CXN%3EQ+GV;?YLXKQAXO\`$W[2OQ<U'7KJVW^,?B-K;70M
M$;?MO;Z<".W4_P`05Y$C'J%'K7JO_!2+PKIGPU_;1\3^"=&*G2OAW8Z3X3MR
M%V[_`+'IELCN1_>=R[M_M.3WKU#_`((4?L^)\>_^"B'AN]NHTETWX=VDOB>X
M5\$&5,0VPP>_FRAQ_P!<L]J\=_X*%>(3XM_X*!?&W4BNSS_&FH0X]!`XMA^D
M(/XTX5D\=]7CM"%_O:M]R6GJ$H6P_M'O)_E?]6?1MK\48?@]_P`&\J:#'(BZ
MA\6_'UU8^63\SP0S++,P]MMJBGI]\?C\'W)E$"B"WN+RY<A8;>!=TUS(3A(T
M'=V8A0.Y(KUSX_\`Q+.O?`WX%>"X'/V+P5X;O]0E0#&Z^U/4))96/KBWM[0+
MG[NZ3^^:]8_X(H_LVC]I;_@H1X5%S$DFC^`HV\6:@'7*L8'1+9/J;B2-A[1.
M>U12E'"8>KB9]Y2?WV7WI+[QS3K584H]DO\`/\SH_P#@K'JEQ^SM\-_@U^R]
M936QL_AEH$.O>*9+:4M'J&NWF]B,%1\L*F5U;^+[6O"F/YOB#7M0DTKP]=W4
M-O+=2V\#RQV\8+23L%)6-0.K,<*!W)%>U?\`!07XMM\<?VZOBWXDW/)!-XIO
MM/MBQR1#9RM:)^'[@D?6O._A_P##S7OBYXPL?#OAC1K_`%_7]39DM-/LTWSW
M#*I8A1D=%4G\*Z,OI^QPL>=ZVYF_-ZMLSQ,N>J^7;9>BT1^RO_!1']E?X<?L
M8?\`!%+7/"4.A>&KG6-*LM.LEU)+.,75WJ\ES"LEYYF/,$C-YAR3D+\OW>*_
M$Y<A@<<=SZ5[9#_P2X_:#@?='\#?'Z,.XT\?_%5-_P`.R?VBPF/^%)_$(8Y_
MY!X_^*KARN-#"4Y0G7C-R;;=TM[>;-\6ZM:2DJ;5E:UG_D?1.C_%?4/@W_P;
MJ3Z7;O)#)\4/']YH0/0M9L[27`'JKK:NA]1(0:^!BI*>^:_;'Q3_`,$H->^,
M_P#P15^''PM@2+0?B+X8AA\3V]OJ!,:#4I/.DFLYB,^7N6YDC+#(5PI((!K\
M;/B[\)O%7[/?Q`D\*^.?#^J^$_$,6YOL.I0^4\Z*<&2%ONS1\CYXRR\]:G(\
M9AZTJRIM<SFWYM='Z6*Q]&I%0YEIRI'Z3_\`!&S]K;]E[PC^SC-\,_B)IWA;
MPQXTUFXGCU/4_$]A%)8^(A*Q$6;MU*QHB;4\J5E`()4DM5'1?^#87Q+J6DVM
MQ:?';PI=VL\8>&:'PG-)'*A&0RL+X@C'?)K\R&570DKD$8(/>O4?V4OVV/B=
M^Q!XL@U;X<^(KJQM87#W&@7,SOHNI@<^7-!RJ[NGF1A9%SP>Q5?*L33G.M@*
MO+*>K4DFF_)O8*6+I2C&&(A=+JM/^'/UX_8^_P"""GAOX._`_P"(/@?XF^)C
MX_T[QYJVF:A(-,MYM&6!+!9&@0XFD9CYTTKDA@,!!C@D_C)\>[?PU9?'[QW;
M>"X#;^#K+Q!?6>AQF=IS]CAG>&)][?,V]4WY//SX[5_1EKW[8&EWW_!/J]^-
MNGQRV>GW'@E_%%M!.X,ENQM#*L+LO&]9"$)&1D'&:_F:TN-XK&)969Y0H\QC
MU9OXB?<G)KS^%ZV)KSK5L1)O5*W2_71:7LDCHS:%*G&$*2_X;^FSUO\`88^!
M5K^TU^V7\-_`FHQ3S:1XAUE(]22%V1S:1H\LP##E<I&1N'3-?N_\(?V3O@=_
MP2;\`>.O&F@6=]X<TK4;>WDUJYGNKC49IEMS+Y$42'<Y8M.X"(,LSBOS%_X-
MR/A4?&_[>VK>))$#6W@7PO/,&*D[;B\E2"+GL?*2YZ]>:_83]LC]G./]J[]F
M_P`5^!3?3Z3=ZU9-_9VHPRO$^G7B?/;SAD(;"R!20""5R.]>=Q/C7+&1PTI-
M0LN9+UOMZ6.G*J"5%U4DY:V^X_$/]M3]O7XT_MS?%Y=8;X7ZBOA32)G/AO0-
M2\$-J_\`9J,-K3.TD#`W$BXWE?E4'8N1EFQ_!'C?]H:P@5M+_9NT'4(UP!(_
MP'AES_P/[(/YURNB^!OV@]!UZ[TB7XEW/AO6M)N7LKZQNOC#;6,UC<1L5DB8
M/?*058$=!TS7JGA#X+_M?Z]*ATSX\,S/]W_B^-O<_H+N2OH7'#TJ:A#V:BMK
ML\].K.3E+FOZ'=?#CX^?MEZ0ZG1OV6?"[,N-I/PG2P(_'S80*]M\&?MK?\%!
M-*18X/V7O!\8Z9_LDV?_`*#J6/TK@O`7[('_``4,U5%&G?'B%$.,>?XXBOOU
M^RRG]:]1\*_L4_\`!1JQ8-)^T1X-BP.EW=&Z_0:97B8AX9O7V/\`Y/\`H=])
M5?[_`.'ZG<^%/VN?V_-093>_LQ_#UU/)W>*!8\?C-+C\J^>?^"K_`,?OVFO%
MEE\/X/%?[.WA3P_-#'J+H]G:P?$/S0QM0<E]/_T`@J.`[&;/./*%?2'A?]F3
M_@H!9E1>_M%_"E0#R6\+&\S_`.08J^(/^"F7BO\`:&M/C==:;XC_`&A/!^K1
M>$+%+2ZN=`\7VG@VWCDP99EGL!J!<21[@#)+M)`&%4#G++J="6*CR*EIVY^U
MNNA6)E45%I\^O?E_34Z+_@C#^V+XV^!7[7L/A?QEX3F\/^#OB9LTZ5[?P<-%
M@M-37_CTG<QP1J0XW0$M_?CY`6OVX0Y05^9W_!'G_@E]XX\.:C9_%GXXZ]XG
MU'5XF$WAGPS?ZW<7D-@,<7]R&E97F8']W'C$:_.V78"/],4&U`.F!7C<05J%
M3%MT+:*S:V;78[<MA.-&T_E?<6O)?B1_R=3\/_\`KTO?_0#7K5>2_$G_`).H
M^'__`%Z7O_H!KR\+_$?^&7Y,RS?^#'_'3_\`2XGK$'^J6G4V#_5+3JYSU#G-
M<^#GA'Q-JDU]J7A7PWJ%[<8\VXN=,AEEDP,#<S*2>`!SZ57^)VG:SX>^#>O0
M>`K+2X?$=KIDXT&VEC6.T%WY;>2K*,`(7QGIP37,_'S]H&;X2ZOI6E:;I']L
MZOJ^6CB:8QJB[@J]%)9F8D`#'0G/8][X3U6YUKPOIMS?V;6%]=6L4US:%MQM
M9&0,T9/?:21^%;RA4A&-26SV_P"&.6EBJ-2M.A!^]'?1Z7\]KGP+^P3_`,$[
M?C1J_P"W)??M%_M':AX=/BVUT\V&CZ1I#))'"[Q^5YK%!L1(H3(B("[,TSLS
M#:-WZ&-A5]!FD615&!QCM09@QQ@^E5C,94Q,U.=E9622LDET2-:-&-./+'\3
M\TOBQ_P3R_:)_;Y_;=T34_C3?^$M'^#?PZ\2W=_H-GI[))=:G8BZ#P1M&I)$
MLT<4"R22,`JAPJ98U^E-SIT.HV<T%S#%/!<(T<L4B!DD5A@JP/!!!.0:E*+&
M,XQB@R[3R#@]ZK%8VI748R22BK))67G\V*E1C"[6K>]SFOA]\$_!GPE-T?"O
MA+PSX9-]C[2=)TN"R^T8SC?Y2KNQD]?6K5S\+O#-YXZM_%$WAW0I?$UI";>#
M5WL(FOX8CD&-9ROF!>3P#CDUN-G'%>;_``9^/$OQ9\6>)M-?24TX>'IQ"LBW
M9F-SF25,[=B[?]7G&3][VYQBJDE*:Z;Z_(FI7I4YPI2T<KV5NRN_P.FM?@[X
M1L=#N=,@\+>'(=,O)%FN+2/385@G=<;7=`NUF&U<$C(P/2MO2M)M="TV"SL;
M:WL[.UC6*&"",1Q0HHP%51@*`.@'%3"4$'/&*1I@O8\\5FY-[FZ2Z%?6]"L?
M$VDW-AJ5G:ZA87D9AN+:YB66&=#P5=&!#`^A&*S?`7PM\,_"K27L/"_AW0O#
M=C))YKVVE6$5G"[_`-XI&J@GWQ6XS[3C!)ZUC>.?$[>$O".IZJL'V@Z9;27'
ME%]@DVJ3MW8.,^N#3BY/W5U)G*,4YRZ#_"W@#0O`UG);:)HNDZ/;S,&DBL;2
M.W20@;02$`!X`'/;BLC3O@!X#T?PU/HUIX)\(VNCW-R;R:QAT>W2VEG(P96C
M";2^"1N(S[URV@?M4Z>/A##XNUO3Y].MIKYK!8+:0W;!@&(.2J=0I[5/\4_V
MAC\/-0\*1VVDKJ,/BG:5DDNC;M;JS1@';L;<<29QD=,5NL/7YN6SOKUZK_(X
M'FF$5/VO,K63VZ2=EIOJ=QXM^'F@>/O#;Z-KNAZ1K6CR;=UC?V<=S;-M^[F-
MP5X[<<5)X.\#Z+\.]`ATKP_I&EZ%I=MGRK/3[6.UMXLG)VQH`HR?05H^:%(&
M#]>U<3\-_$7C'5O'7B"VU_2+6PT6UE==+N(SEKI!,ZJ6^8\F,(W0?>_"L8J4
MHO71>9V5*L8SBFG=Z;?/5]#N:*89AV!(I!<`KG!QUK.YL244Q9=SXP:#,!V.
M/6F`^BHVN`N,@\TOGC.,$'TH`?13'G"'&#2-*&&.<F@"2BO-OA;\>)?B1\2/
M%&A/I4=BOAR>6%;A;LRFY"3O%DIL79G9GJ>N/>M[XO?$%_ACX`U#7DLQ?&Q"
M,+=IC")-SJOWMK8^]GH>E:RH34U3:U=OQV.2&.H2H2Q$9>[&]W9_9O?STL=7
M17F=K\:M0O\`PSX,U2+2-/$?BU_+,<VJ/&UJWE2387$+>8-D3_W3G`Q@DC@=
M?_;P_L32],G'AB&22]A\R9)-8\I8&(5U56\D[PT4D4@;`XE`QQ6D,'6F[17X
MHYJV<X.E%2J3LGY/R?;S1_/'\?=0.L?M$?$J[SO^T^,M<D##^('4KG!_+%<N
M%PF,MM!W;<\9XR<>O`_(>E=OXA^"7Q#UGQ1J^H'X=_$(G4=0N;PG_A&;[_EK
M,\A_Y9?[54F_9U^)^IR):Z=\-?'TVHW;I;6D4GAV\C22>1@D2LS1A54NR@L2
M``220`37[+"K3C!)R6B[GS$HS;O9G[!?\&UO[/0^'W[*GBCXB7<174/B3K(B
MMV/:PL-\,0'UGDNVS_MCT%?CG\7O$C>,?C1XTUAI/-;5O$.I7F_^_P"9=RN#
M^(-?TT?!3X46'[*7[,OA[PCI2-<6?@70([./RXSNNVAA^>3:,G=(X9L#NU?S
M,Z+\!_B)<Z7;3/\`#KXAB2>,2MGPS?`Y89.?W77FOE>'L6L1BL3B9/1M6]-;
M?@D>MF5%TZ-*DEM?]#G=N#DEF(&!DYP!T'TK]O/^#<7]FD?"W]D35_B%=*PU
M3XJ:D)D)Q\MA9&6&W7\9&N7_`.VE?D+X!_9$^)GQ8^(.@^%;'P1XXTR\\2:A
M!ID5Y=>'[N&&S,KA#,[M&%58P2Y)(&%-?TU_##X;Z3\(/AGX>\*:!;"TT3PQ
MIMOI6GP#D16\$2Q1K[X512XNQ\50CAX._,[OT7^;_(>38=NHZLEM^O\`P/S/
MY/\`P;<2ZAX3TN>=WEFN+2*:61CDR.Z!F8GU)))^M?>?_!N_X0LO$_\`P4BM
M[J\G$<OA[PEJFIV<>1F>;S;2VV@'KB.ZE;CGY!VS6!_P4_\`^"47CG]D#XT>
M)-=\,^&-5U[X5:M>SZIIU[I-F]RNAQS2-(UG/'&"T:Q,Q5&QL,>SD$%1\31?
M$?08;CS8O$6E03V[$AX]3CCDB;H>0X*GDCMUKZ"3IYCA)1H2TFK::VOW7X'G
M)3PU9.I'X6?JQ_P5T_X*_P#Q.^%?[:>J>#OA)XUCTCP_X4T^WL-0$%K;7:W&
MI%I)9SN=&(**\,14'`:)NYP/*OV0?^"GG[57[3_[4O@'P#:_$NX9/$6MVT5Z
M4T:S)CLD<2W3<1@C]PD@SG@D&OC;X"?`SQA^T[JRZ?\`#/PKK7C63?M+Z-;&
M>UA)/\<X_<I[[G%?MY_P1Z_X)$#]A:SNO''CB:PU;XH:Y:_9%6U<RVGART8A
MGMXG./,ED*H99=H'R!$^4,TGA9C#+\NP?LW&,JEK+17;[O>W?7T._#2Q.)K\
MUVHW[NWH?/'[;_\`P7S^+O[/?[7?Q`\">%O#GPUNM!\):H=.MI=3TZ^ENY"L
M:%R[1WD:'YRV,(.`.O6E_8I_X*M>*O\`@IM^TQX?^#OQD\#?!G4O!/B&*[GF
M@?1;EI6GAMI'B$1GNI463.<$)NQNP0>:\N_X+B_\$X?'O@7]J7Q+\5O#/AW5
M?$W@CQFRZC>S:5:/<RZ+=K&J3+/&@+B-]HD60`CYF!P5!;\WY?'N@+<LC:WI
M,4\#_,IOXXY874]QN#*P/T(K;`91@,5@XRH17,X_$KW4K;VOO<BOC,12KN-1
MZ7V[H^VO^"V?[(_PM_8W_:=\/Z!\,+BYM_[9TB74=<T*2Y-S%H,GFQK;>6[$
MN!.AG8QL24$",.)17QU=&2.W806]Q>7#86&V@7?-<R$X2-!W=F(51W)%7/AE
MX?U+XZ>)6T[P5I^I^-]9N),O#HD+ZI.SGO(8MV"<=7(Z5^L?_!(K_@AYX@\`
M_$K2/BO\:K2WL+G0V6[\/^%0XEFAN@<I=WC*2@,?5(5+?-AG8%0E=];&T\MP
MJCB*G-)+KO)^GX7.>%">*K-TXV3^Y'>_\%2=.NOV-O\`@AGX:^&ES-`-7NK+
M0_!]V86\Q)95"37>P\':?(EP<=",CFOQ9`Q7[F?\'#O[./C/X]?LG>&;OP;H
MFH^(Y?!_B)=2U#3["%KB[>V:VFB,J1KEGV,ZY"Y."3@X-?A5JFJ1Z!=-;ZB)
M=.N$.UHKR%[>13Z%7`(_*N+A6<981RO>3DV_P-LW359*VB22/TX_X-[/VH?A
M)^S3X?\`B3%XX\::7X:\7>,==TVRT^RO$</?6T<6R#R2JG>S7%S,FP<@A3CY
MJ_9O.]#CZ5_-O_P2<^$%W\</^"A?PGMHM.O[K2M.UM-9NYQ:2_9DCM(WN%W2
M%=@^>-,9/)Z<U_24!BOF.+*%.&,YHN[DKORZ+\CULGJ2E0LUHM%^9^-W_!?W
M]@W0O"/QUTWXQ2:\?"^@>.S'I>L.NBS:BL>J1QL8Y2(F78)H$QSU>#KEJ^&=
M-_9S^!NL1`ZE\?+.U)^\C?"[4+C'_D<`U_15^V!^S)H?[87[/'B;X>^((W^P
MZ_:[8YHW$<MI<(PDAF1BK;6615.=IXR,'-?SL:MJ'PN^&7B[5?#OBWX,?$!-
M?\.WT^F:I;Q_%2*,0W,,C1RH%_L7.`RG!W<C![U[W#F85<1AO8J4N:&FG)MT
M^)?(\_,L-&G5Y[*TN]]_E]YU'A_]AW]E3574W/[4^CZ>6`W>9\'+V,C\?M+?
MRKT;P)^P/^QA:W2FZ_;(NX&&.=,\+?V20?9IHY<5YQX;^,W[+=HR_P!J?`;X
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M.YG*EF^0`R?KNB;>>YZU\KFV;2H1EA:$Y-OXF^73^ZFOQLSU\)@U4:JU(I+H
MM?O=_P`-!50#![XI:**^1/8"O)?B1_R=3\/_`/KTO?\`T`UZU7DOQ(_Y.I^'
M_P#UZ7O_`*`:Z,+_`!'_`(9?DSR\V_@Q_P`=/_TN)ZQ!_JEIU-@_U2TZN<]0
M^6?VE_#.IR_M*:'$FMRI+JYB^P2>5SI7[S9\OS?-\P+]NN/>K.I^']:^,GQ[
ME\#ZCXHU6VLO#FF(9)K5C&UY)''`KR%<XWN\V<MNP%P/6MS]HG2KN[_::\!3
MPVEW/!$8?,EC@=D3_2#U8#`_&LWQGJNH?`+]I_5O%EUHNHZIH^M6A@CDM$W%
M2X@)&>FX&#H2,AL@\8/NTYN4(*-N;E=MM[_Y?U<^"Q5",*]6<[\CJQYM9?#R
MWUL]K_Y=C*\(>,-<T'P/\5?"MUK%]?CPW`XL[QI76:/;(T9VMN+*#M4@;C@Y
MYKK/V6?`&MZ[9Z!XPO\`Q->WEK;QW5M#ITV^0*#)(A8R%^6W9/*GC`SQ7(>$
M?"^LZ]X(^*_BNYTF\L8O$5O(;2U>-C+)ND:1MHP"P`*C..3G'2O9/V3;2:Q^
M`VC17$,UO*KW.8Y8RCC-Q(1D'GH14XR:C3ER;MJ__@.IKD]&53%4O:W<5"3C
M=OI4]WUTVOT-CXTZ1XCU_P`$7%EX8O;;3M1N&57N99#&8HN2Y5@#AN`,XX!)
MKYJU'4$^#GQ$\.'P]X[O?$.IRSI'K4?VHS6ZN9(P5]&5@SCDLPV9SSBO7_VV
MDUJ;X41Q:4ET]K)>*-1$"LS&'8V`0H)V;]N?PSQ7D'C>2U\0V_@9?#7@W6]'
MT;3KG#3RV1#7<ADMR[';DD+M^^QYR<<+2R^'[M7>COV[=>OHD/B&K>O)034X
MJ+3O+^;[*6B_O-^A]A1#:I'7!KY)^%7@.;X@>(/B;"-:U32+2SFEN)H[%@CW
MCB6Y\L.YY"+AB5'WBPY&W!^MD.<_6OG/]G#2;RQ\1?%@SV=Y`+C?Y)D@=!-^
M]N_NY'S=1T]17)@JCC2J26^GYGK9Q157$8>,E=7G??\`E?8YKP]\8/$&@?LA
MSS6U_<M?-K']G0W#2EYH8C'YFU78D@\%03T#>PK"/CBU^%5_H.K^%_&^KZ[J
M$SK_`&Q:732>2Q.TL`&&"I)9>2S`@'=6GX9^&.M^+?V1M0M+33[U;^SUS[7]
MG>%DFE00A"44@$D;L\==I[UK:3XW_P"$YO/#^B^&?AMI4&HQA(]5N-3T.-XX
ML;59PV`0!AFW-@DX&,UZUX)RY5=7=]K;+?R[6/DU[:4:7/)I\D.5VDW>[ORV
M:5]KWZ>1V'QU\!W^O^-)=0\6>-(_#/@F",K:Q6MV8IW<*.JE<,Q)8DX8@```
M9R.4^"?C2^UOX._$K2I]3N-7L-*LW:QGG9F=HV64`Y8D@,$5MI/&XBHO$&H?
MV3^U-K%YXL\-:UXD5,QZ);P6IGCQN7RBH)"E=N[G)`8DD=POP<TG4E\._&!K
MO2KVQN+VW=UMWA;ABUP2B':-^TG&5Z\>M8*%J%I._P`+6UMUMU]6=[J<^.<Z
M::NZB=^9MVB[7Z)?RI'':_IMR_[*FAWRWC+8V^LW,$MEM^6>1@624MG@J$9<
M8YWGFMWXN>%]7\/6'PV@N]=DU.[NY/.M;F6#_CS5VMO+3:6.X)UZC..U/O\`
MPCJE_P#L86\$>FWYGM-=>YFB-NXDCBPZE]F-Q&6':I/'7BJX^*%I\-+RTT75
MX$TRX%E,'MV?!C>V!?('"GG!..A]*W4[S35K*4NW;0\Z5&*I--/F=.E;?I)7
M^[3TZ;LWM)TB^^%'[7ND:5#KVMZM#JT.^\:_N#(9RT<I.0,+PR`C`&WH.*?\
M)O'.HZ%\1/C!>-=W=X-):\FMH;BX>2*(I=7&T!2<*.`,#'``K6\>Z7=R_ML>
M&;E+2[>V2W3=.L+&)?W<_5L8'4=^XK'^$W@R_P!=^(GQALC;W-I_:K7D-O+/
M"\<<A:ZN-I#$8(.0<C/!S7-*4)0YI?RJ_P#X$>K"%6GB5"E>RJ3MO_S[TW\S
MS:/Q'!J7@^[\17GC_7X_'*3%[>R6201,NX<9`P"1DC!"C`!4]^R^)/Q%U_Q?
MH/PJU"'4[BPU/5%DCDD@E=(I)1/'$)'12`PR-Q4\<D=*R?"?BH?#WP--X:NO
MAP=0\9)<LL$UYHZ7*,K/GDXW-@9``)!X.X"NG^+GAS6%O?A.MSI$-O=PR"2[
MM],M"MM9EIX6V;5R%P#SSC(8UTR<?:*ZZNVVUGVZ;;GF4(U'AY\LG>T.9)2^
M+G6K;?Q6O>W0]J^"_P`-;KX7^&KBQO=:NM?N+F\DNVN[A&5SO"C:<N_=<]>_
M05Y??>*;OX6?M=ZU)=WE_/I&IZ--=Q6LERQA1U1),JI)`.;>0#`'^M->_1?Z
ML5\[_MR^%[XR:%KFGVMY<2JL]C+]FB:1P"I=<A02`5649QCMW%>1@Y>TK.,_
MM)_YGUV<TWA\'&I03_=--+5Z;-=6]&<7\&OB]JVA^`O'\6H7U_<7<^CC4+62
M>XD8QNS>42A))4$S(1MQC%2ZEJ7B)/A]\.?#`UK5+)O%S&]NKDW$DDS)-,%A
M!8L&VB(J2FX9)IOQ]^$6IZ#=>$+/3[2]D-_H5MI5T8(6=?,1E#!R`0!DJ>?[
MM=O^TYX+O_"6L^"-?TW3;C4M.\+^7!+#;J2R+&RLF0`2%(4C=@@$#/45ZG/2
M<XN-O>N_N5E^)\PJ.*C2J0J-VI**ZZJ4U*6W9:/R*/@NRU+X`?M+:3X6AUS4
MM9T?6809([QRQ0LLA5@,X#!H^J@9#$$=ZQO@3X-U[XO>(-<#>+=4L[#1=8BN
MGMW>2X^U,)'(4DR+M0!2,<@ELD?**V/!>HW_`.T%^TSI/B>VT74M+T?180)9
M;M-N2JR`*#T+%I!P"<!23Z5K_L7:7=Z=J?C@W5I=VHEOT9#/"T8<9EY&0,CG
MM656;A3E)VY[1OMO?_(ZL'2C5Q%."O[%SG;67P\JZ[VNCG/A/KLOA?XD_&;4
M8`#<67VZ>//0,MU.1^N*YO3O!5_JW[-NM^,+CQ'K<US=S^7<6DL_FVUT@F0'
M<K9(?=\P8$8P!@@FNJ^&'@S4-;^(7QBLQ9W4#:FM]#;O+"T:3,US-MVL0`<Y
M'3UKF?#WBO4O^&==:\$#PSX@?4[:9I9Y1:E8K=/-5FW9Y+@@J%`).0>@-;)^
M^W#>\+[;6.)Q_=*-5.W+6Y=_BYG;;K8^A?V;HA)\!_"N1G%@F/;K7;?9(\?<
M7`Z<=*X[]G.VDM/@=X8BFBDAE2Q0,DB%&4\\$'D5VM>#7_B2]7^9][@%_LM.
M_P#*OR0U8]O<G\:%CQGDG\:=161V7$*`X]J;Y7^TWYT^B@+C1%@_>)^II57:
MH'I2T4`-,><\D?2J>H^&M/U>XCFN[*SNI8ON/-`DC)]"1D=:O44+38+#?*YY
M)/XTJKM&*6B@!K1Y;/2J>J^&[#7507UE:7HCY7[1"LNWZ;@<5>HH6FP>I'%;
MK#&J)\J(-JJHP%'H`*>J[1BEHH`0KDTTQ9_B;\Z?10`T1^Y/XTZBB@!&&5(]
M:_(7_@O[\#+K]GKXM:!\8?#O@WP?JVD>.)1I?B"34/#L-^T.J11`V\KY&XB:
M"-DR1@-;*"<R**_7NN!_:>^"*_M&_`;Q1X*_M;4]`FU^Q>WMM4T^=X+G3;@?
M-#.C(RME)`K$!AD`C/->AE>,^JXF-5ZK9^C_`*N<^*H^UI."WZ'\ZT?[9>O6
M]N(S\)?@QM88#/\`#6`D_B5K[1_X)2?L$ZE^WO=1_$7XF_#[X;:/\*8'=;"P
ML?"5O92^*Y02I(QREFC`AFQF5AM&%#%J_P#P3#_87_:*_:6^+.J?\+>^(GQH
M\/?#OP%JDNF:KID_C/5E'B6^MY"DEI`?/&;0,I+SCAU*JGWF9/V:M;5+.!(H
MU"1QJ$51T4`8`KZ?/,WIT4\/A4N9[R3O;T\_/IZ[>5@,&YOVE2]ELG_PX6MK
M'9P)'$B11QJ%5%&%0#@`#L`.U2445\0>Z%%%%`!7(^)/A<OB#XGZ#XF-Y+%)
MH44T2VPC!6?S`1DMG(QGM774549.+O$SJTH5%RS5U=/YIW7XC8AMC`/:G445
M)H-\H9)Y&>M(L`4\$C\:?10`WR\]S2JNT=S2T4`-*`MFCRAGJ?SIU%`#1$`I
M'8TA@!`Y/'O3Z*`&F($=32>5D\DG\:?10`WRQC'.*/+Z\G\^E.HHL`P0@-G)
M_.@PY_B;\Z?10`WRQC'.*!$`,9)&,4ZB@!OE`=V_.CRAMQDX^M.HH`0#:,4G
ME`$GD$TZB@!HB"G()&:#'^%.HHL`T1#.2230T6[N:=118!IB!/)-!B!'4_G3
,J*`$1-@I:**`/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>westlogo1022014.jpg
<TEXT>
begin 644 westlogo1022014.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!5`-(#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_**^=_VB
M_P#@JM\"_P!E#XH3^#/'GC)M%\16UM%=R6HTN[N-L<H)0[HXV7D`\9S7"M_P
M7H_99123\2'`')_XD6H?_&:]6ED>8U8*I3H3<7JFHMI_@>75SO+J4W3J5X*2
MT:<DFOE<^PJ*R_!/C+3_`(B>#=)U_29FN-+UNSAU"SE:-HS+#*@=&VL`RY5@
M<$`CO7S%XO\`^"WO[,W@7Q=JNAZC\11'J.BWDMA=I'H]]*B31.4=0ZPE6`92
M,J2#C@US8;+L5B).&'IRDUNDF[>MCHQ.8X7#Q4Z]2,4]FVE?TN?6-%?-7P+_
M`."NOP!_:2^*VD^"?!OC:35_$NN-(MG:?V3>0^:8XWE?YWB51A$8\D=*]K^-
MOQK\,_LZ_"W6?&GC#4TT?PWH$(GOKMHWD$2E@@PJ`LQ+,H``))(HKY?BJ-54
M*U.49RV333=]%9=;O0*&886M2=:C4C*,=VFFE;5W?H=517Q]_P`/YOV6O^BD
M/_X(M0_^,UZQ^RI_P4&^%'[:^J:S:?#;Q'/XAE\/Q12WY_LVYMDMQ*6$8+2Q
MJ"3L;@$G"FM\1DN84*;JUJ$XQ6[<6DOFT8T,YP%::I4:\)2>R4DW]R9[3111
M7F'I!1110`4444`%%%%`!17*?%/X[^"?@;:6=QXT\7>&O"4&H2-%:R:QJ4-D
MMRZC+*AD8;B`02!TKC/^'@7P*_Z+)\+_`/PI[+_XY713PE>I'FA!M>2;.>IC
M*%.7+4FD^S:1Z]17._#+XO>%?C3X??5O!_B30_%.EQS-;->:5?1WD"RJ`60O
M&2NX!E)&<C(KHJQG"46XR5FC:$XR2E%W3"BBJ'B?Q-8^#M"NM2U*XCM;*SC,
MDLCG@`=AZDG@`<DD`<U)1G_$_P")NC?![P+J/B/7[M;/2],B\R5\%F;LJ(HY
M9V.`%'))%?FL/^"C_C7Q'^V%HWCV\LM9LO!6G3-8#1TAD:*'3Y2%D=\##S\+
M(3V*!1QUO?M4?$?XZ?M:_$<77AGPUXPT7PMIC%-*M+2X6WDD'>>8JXS(PQ@=
M$'`YW$\!K?[.W[2XT:2]U"P^(+6<8R[2ZYD(/4CS^![]JM)=0/UTL[V+4;.*
MX@D66&=!)&ZG*NI&01[$&I<U\A_L(?$#QCXV_99U?P+JZ75OXN\+!8;8R7T?
MVB_L6<,`LBNQ5PH>'>2-N8SGG->I_LG>`/$G@B;5/[56^@L)47;'=''F3=2R
M1EF*!1E68GYR<C@"H`]IHHHH`_G>_P"#@+5!J/\`P5(\;(#D66G:5!]/]"C?
M'_C]?&4-B^J3QVL0W273K"@]68A0/S-?4_\`P6VU?^V?^"HWQ8?(/V>[L[?_
M`+XL;<5XQ^R3X+/Q'_:L^&6@!/,&L>*M,M64]U:[CW?IFOZ?R1JADU"3^S3B
M_P#R5,_E_.HNOG5:*^U4DO\`R:Q_1O\`M6_&.#]AK_@GYXB\2!EBF\&>%TL]
M.4G&Z[\I+>V7\963\,U_,1-/+=3/+/(TTTK%Y)&.6=B<EC[DDFOV6_X.?OVC
MO[%^&7@'X4V=P!/X@O'\0:G&O!%O;YC@4^S2NY^L%?C1M.W.#C.,U\UX<9>Z
M67RQ<_BJRO\`):+\;L^E\2,P]KF$<'#X:4;?-ZO\+(^TO^#??0_[8_X*A>#Y
MBNY=-TO5+H_[/^BO&#^<@K[O_P"#FOX^_P#"%?LK>$_A_:S!;OQUK/VJZ16Y
M-I9J'((]#-)!_P!\&OD7_@VH\/'5O^"@FK7NW<NE>#KV0GT+W%J@/ZG\ZYK_
M`(.$/C__`,+E_P""ANIZ);SB;3?AWIMOH404_+Y[#[1<'Z[Y50_]<O:N?&X/
MZYQ?3OM2@I/Y-V_%HZ,%C/J?"%2VCJS<5\[7_!,^'"<"OZ#_`/@W_P#V7O\`
MAGW]@;2M<OK;R==^)5P?$-R67#K;,-EHA]O)42#WF-?AM^R)^S_>?M4?M->"
M/A[9*^[Q1JL5K<2("3!;`[[B3_@,*R-^%?NQ_P`%"_\`@KG\.?\`@F?HMCX*
MTC35\4^-;:QBCL_#MG,(8-)MP@6%KF7!\I=H&U`"[`9P`0U/Q`JXC%*EE&#B
MY3F^9I=EHK]$K]7V)\/J6'POM<WQDE&$/=3?=[V[NW1=S[2)`HSQ7\]WQ5_X
M.%/VE?B'J4TFEZ_X>\&6<A^2VTG1HI#&.P\RX$K$^_'TKEO#W_!=']J7P_J"
MSGXG/J`7K#>:+821M[$"%3^1KY"'AGFKCS.4$^UW^D;'V$_$W*8SY5&;7>R_
M^2N?T=45^;G_``28_P""Z,W[87Q'M/AI\2])TO1/&6H1.VDZGIVZ.RU=D4LT
M+1L28IMH9AABK[2!M.`?NC]HW]I'P?\`LI?"/5/&_C?6(='T'2E&]V4O+<2-
M]R&)!S)*YX"CW)P`2/D,PR3&8+%+!UX>^[62UO?:UM[GV&7YW@\;A?KE"?N+
M=O2UM[]K'=YQ1D`=:_#S]IS_`(.7OB=XXURXM_A;X>T7P/HB,1!=ZG`-1U.9
M>S,"?)CSUVA7Q_>-?/\`-_P6_P#VI9KLS?\`"U[U,MNV+H^GA![8\CI7U6&\
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M6OWGA[+I8#+J6$EO%:V[O5_BS\$XBS*./S*KBH?#)Z>BT7X(_H]_X(>_"`?!
M_P#X)G?#>)HO*NO$-O-K]P"N"QNIFD0G_MEY0_"OK2OR]_X(6_\`!2/XI?M=
M_$J3X>ZOI7@[3O`WP^\)Q"-M.L9HK@-&T5O;1EFE9>5$A/RC.SC%?IUJNJVV
MAZ9<7EY<0VMK:1----,X2.)%&69B>``!DDU_/?$^$Q%#,ZJQ-N:3<M'?XG=?
M@?T-PQBZ&(RVD\-?EBE'56^%6?XD/B;Q-8>#?#]YJNJW=O8:;I\+3W-Q.X2.
M&-1DL3Z`5^9G[;W[0%]^VAXL73-,\:^`M$\!Z9-NL;2]USR9-0D'`N9UV'!_
MNH?N#GJ3BU^W+^VSX<_:OU;_`(1RQ\9ZKX?\$:?+EDBT![@ZO*IXF<B53Y8/
M*)C_`&CS@#Q?1?A?\&;L#[;\7]?M2>R^"IF'?OYQ]J\.,>K/?)]!_8O&M%2/
MBK\%;8'^_P")L$?AY8]J[C1_^"<U[JMN8_\`A=WPD\F48:.+7WE##T*\`BLS
M1O@+^SI>8%S\==<C)]?"TL7\U:NLT7]ES]E2XV_:?CCJ,N>H:W2W_P#0H#5-
M@9?PR\$77_!.[]I_0M;F\=>`M1TW8%O197[[KVQE.V;Y%1AN1EW`%LEHU]:_
M532]1M]8TVWO+26.>UNXUFAEC.5D1AE6![@@@_C7Y6_'W]F[]G7P7\-X]2\&
M_%>]O]0CND26!/)U*66-@1Q"ODD8.TELG`[<U]6_\$JOVA]+^('PDE\"QZS=
M:MJ7@E0L,MU:?99)K%R?*PN]\^6<H3G@;*B7<#ZLHHHJ0/YE/^"LFJ?VQ_P4
MH^-$V<[/$LL&<_\`/-$C_P#9:UO^"-7@P^.?^"G'PBM@NY;+59-2;C.!;VTT
MP/YH*XG_`(**ZG_;/[??QIN0<B3QKJJC_@-RZ_TKM/\`@EO\3T_9\^*WQ`^)
MK2"*X\`>`-6O-/8_Q7]P8;*U7\9;D?@#7],UH361>SI_$Z2BO5Q45^+/YEHS
MA+/O:S^%5')^BE=_@A__``6(_:-_X::_X*%>/]6@N!/I&@70\.:85.5\FTS&
MS+[--YS_`/`ZXW]HWX.#X,?LX_`[[3"8=7\<:1J'BZY#+AA!/=+;VH/L8;8.
M/^NIK@?@=\)M3_:'^-WA7P78/)-JGC#5[?31*3E@9I`'E)_V5+.3Z`U]A_\`
M!PS;V/AC]MCPSX1TI!#I7@GP)I>DV<(/$,:O.57_`+Y*TH.&%Q&$RNCM&+;]
M(QY5][E?Y%3C+%8;%YI67Q227K)\S^Y*WS.W_P"#;37+'X=_%CXU^-M4;R]-
M\*>"1<74G]R(3&9__';<_E7Y[_%/XCW_`,8OB=XC\6ZH[2:CXGU.YU6Y+')W
MSRM(1^&['X5]!_LM_%A?@I_P3C_:-GAD\K5/'][H/@ZS(.&,;_:[BZQ[>1&5
M/_705\O8..%+'LH')/H*TR[!VS+%8QK5N,5Z1BF_Q?X&698R^6X3!QZ*4GZN
M32_!?B??/_!'1K/]E3X.?&K]J+6;2*X7P%I7_".^&8IA\MWJMT4R!]-T"MCG
M;,_I7PYX\\=ZQ\4/&VK>)/$.H7&K:[KMW)?7]Y.VZ2XF=BS,?Q/`Z```<"OT
M%_X*B>"&_8J_X)@?L\_`X;;?6?$$T_B_Q-&HPSW0C!VOZ[9+DH/^O=?2OSDZ
MFLL@Y<3.MF>_M)-1?]R'NJWJTY?,TX@<L-"CE>WLXIR7]^:YG]RLOD?<'_!$
MS_@F7X?_`."@WQ+\5ZAXWEU)?!?@NW@66WLI_(DU"[G+^7&9`,JBI&[-MP22
M@R!FO'/^"GW[.OA7]D_]N+QOX!\%3WDWAW0WM3;K=3>=+;M+:Q3/$7P"P5G(
M!/.,9SUJ#]DS_@I)\7?V(/"VK:-\-M>T_1;'6[L7UZ)M)MKMYI0@0'=*C$`*
M.@XZ^M>7?&+XN:_\>OBAKGC+Q3>C4?$/B.Z:\O[D1+$LLA`'"*`J@````8`%
M:8;!YBLVJXFM47L'&T8IO?35JUK[ZWZV,\5C<M>44L+1IOVZE>4FEMKHG?;;
MIT.S_8+U.\T;]N#X/W.GLRWD?C+2A%M."=UW&I'T*DCZ&OK/_@XS_:NOOBY^
MV-'\.+6[<>&_AI;1JT"-\DVHW$:RRRL.Y2-XXQGI\^/O&O$O^",_PQ?XJ_\`
M!3'X4V:INBTG4GUN8D9"K:0R3`G_`(&J#\:T_P#@MI\$?$/P<_X*-?$&[UJT
MN(['QE>_VYH]VRGRKVWD1`0C="8W#(PZC:.Q&>.NL/4XCI*=N:%)M>KE;\%?
M[SMP[Q%/ARK*%^6=1)^BC?\`%V^X^8?!6C6?B/QIH^G:CJ,.CZ?J%]!;76H3
M*6CL(GD57F8#J$4EB/\`9K]9OVX?^""?@/1_V1=.U[]G[3O$_C;QF+FU\F6#
M68KR#6;5R1+,=Q6(`#Y@8R!VP0:_(:O6/V:/VYOBS^Q_J"R_#SQQK.@VN_S)
M-.\P7&G3GOOMI`T9)]0H/O7;G6`Q]:=.M@*W(X._*[\LO*5M?S.'(\PR^A"I
M1Q]'G4U;F5N:/I?3\CT'_AS=^T]G_DCGB3_P)L__`(]7W9X@_P""/_CWXV?\
M$OO@WX>\8>++?X:R_"FTUS6-8T[4-/-_*K37#RH"8Y@JA(5)P"W^L/TKNO\`
M@EQ_P7R'[4GQ-TGX;?%#1--T'Q7K;>1I.L::66PU*?&1!)$Y+0R-@[2&96;Y
M<*2,_2G_``61^+I^#'_!-CXJ:C'/Y%WJ>E#1+8@X9GO)%MR!_P``D<_@:_.L
MWX@SQX^A@,13C3GSIQ:5[WO&ZNVFK2?2Z/TC*.'\C6`KX[#5)5(.#4DW;:TK
M.R3O=(_FK5Q(H9<[6Y&1CBO5OV)_V5-2_;7_`&F/#?PVTK4(M(N=?,[/?RP&
M>.SCAA>9W9`5+<)MQD<L*\J`"C`Z#@5^E7_!L9\)1XH_:W\:^,)HB\/A+PZ+
M2%^R3W<R@?CY<$@_X%7Z9Q!F$L#EM;%0=G&.GJ]%^+1^7\/9?''9E1PTU>,I
M:^BU?X(^_/\`@E#_`,$M3_P3'TOQW<ZKXNT_Q5>>*GM6-W%8&Q2RM[=93M.Z
M1\Y:1F)R`,"O'_V]/^"B>@_'+4;OP3I46O7/@FTFQ=7FF7\=J=<=3T^>)SY"
ML,CD;R,D8`K[%_;\\*:YXO\`V5O%$.@1K=75K"+N>Q8R!=2MXSNE@)C96^9,
MG`/S%0IR":_*?0_CQX=T=%\[X6_#J_7@CSVU`$_^37]*_FO&XZOC<1+$XE\T
MY6N]%LK=--D?TU@,!0P5".&PT;0CLM]W?KYFEHOB3X*Q8^W^$/B9,>YB\1V8
M7\OLP/ZUU.C>-OV9X'!O?`OQ3;'7.N0N/T9*SM&_:\\&Z85\SX%?"F;''WKD
MD_\`?;M7<^&OV^O!.F;=O[.7P\E]X$!_]"@:N;8["UH/Q0_8[AV_:_`GQ`!Z
M$RWC2#_QVY'\J[#1/C'^Q-D#_A"-65AQFXM+N;^4S5;\,_\`!1SPLNWR/V9[
M;V-C9Q'\L6O]:]$\+_\`!1&SN=@MOV<_'<?_`%YZ.CXZ=/W:U#`\T^,?Q,_9
M(U7X-:W'X=\)2_VL8T-NEEIL]A>%A(APES)&Z1\9R6SD9'4UXC^SG^TMX/\`
MV<?CCH_BK0M`\5V=O`QMK]+G7(;A9+63`D!1;9=VT8<#(^9!S7TQ^V+_`,%!
M+.Y^"/\`9&I?!O7[!-;N8XUMO&&GM::?=+&1(P!CD61G4A2`,#U]_E?X=7\O
M[1_Q!L?#'A+X2_#\:IJ+846ZWXCMD'WI9&-R0L:CDG'H!DD"A+0#]DM*U2WU
MO3+:]M)DN;2[B6:&5#E948`JP/<$$&BO$/!W[$__``C/A'2M-/C/Q+"=/LX;
M;R[2YDCMTV(%Q&I<E4&.`22!CDT5('\X_P"UMJ?]M_M7_%&]SG[7XOU>;_OJ
M]F/]:Y#3/%=[H_AW5=+MY/+M-;\A;L#K(L+F1%^F_#?5%]*M_%'5AK_Q0\37
MX((O]7O+G(.<[YW;^M85?UG0I)480?1+\#^2<35;KSG%[M_B?H=_P;<_LZGX
MH?MIZIXYNH!)IOPWTAY8G9<J+Z[W0Q?B(A<'V(%>9_\`!>CQ,/$O_!4?XA*K
M;DTRWTVQ'MMLH6(_[Z<U^H?_``;V?LX_\*3_`."?NG^(+JW$6K_$F]EUZ4E<
M/]F_U-JI]O+C\P?]=C7X]_\`!5GQ%_PE'_!2+XT76[>$\3SVH/M"J0_^TZ^`
MR;&_7>*<353O&G#D7RDK_C<_0,ZP7U'A;#TGI*I/G?S3M^%CQ%O%UZ?!:Z`)
M"--6_.I&,?QS&)8@Q^B@@?[QKZ'_`."07[+H_:P_;Z\$:)=6WVG0M"G/B+6`
M5RGV>U*NJ-[/,88_HYKYEK]L_P#@V9_9?_X0?X`^*?BK?V^V^\<WW]F::[J<
MBPM20[*?1YRX/_7!:^@XNS)9?E56K#24O=7K+K\E=_(^>X0RUYCFM*G/6,?>
M?I'I\W9?,^5?^#E;QQ+XC_;^TG2&)\GPYX3M(T7MNFFGE8_B-@_X#7YZ2OY<
M;-UVC-?I!_P<P_!74_"7[9/AWQRT$K:'XOT"*RCN-I\M+JU>0/$3T!\N2-@.
MX+>AK\X'7>A&<9K3A&5-Y/A_9[<J^_K^-R.+XSCG.(]I_-^'3\#][O!?[!'[
M.G[*7_!.'0O'OQ-^%7AG7KWPQX0M=5UZZDL$EOKVX:%'=07909&D?8N2!G`R
M*^5Q_P`%&?V`"/\`DV+51_W`K#_Y*KY[_;'_`."TGQ,_;+_9NTKX8ZII6A:!
MHT`M_P"UKC3FE,VMM`%,88,=L:;U5RBYRRCD`8KY1\&^#=6^(OB[3=!T'3;S
M6-;UBX6UL;&UC,D]U*QPJ*HZG/X`<G`%>!E'"V(=.I6S>K-2<F[1J-)1^3MW
M]$?09MQ7156G0RBE!Q44M::;<OFK_P#!/W/_`&!OVH/V29?`OCGXU>#/A;'\
M)-'^'0AT[4]?O=(CCD(NBH\J(6[RLW/E!@!GYU]ZV/VB_P#@I?\`L-?M9^`7
M\-?$'Q=HGB726)>-;G1-1$MHY&/,AE6$/$_^TA!_"O-_VBO^"?&H?LC?\$`?
M%O@2UC6\\40);^)_$SVPWB:<7<$MP%(^\D,,84'NL.[O7XF[O0Y%>-DO#>`S
M:K5QM.M47)-QBU+6R2L[M-ZMMH]G.^)<?E%*E@ZE&F^>"E)..EVW=632T229
M^E^N?\$,O!7[6GP\U'Q[^RK\45\3Z!;7DMF-+\1VTUO^^C5':**Z,:$D!UQO
MCQSR_6OSF\>^!-7^%_CC5_#>OV,NF:YH-Y+87]I*07MIXV*NA()!P0>02#U%
M?5G[!O\`P6=^(/[`7P)UCP'X=\.^&=<L;Z]EU&QN=1,JR:=/*BJYPA`E3*!@
MIP<YYP<#Y1\;>,M4^(WC+5O$.MWDNH:QKEY+J%]=2?>N)Y7+NY[<L3QVK[C)
M:&:4:]6EC)<U)?`W;F:\[6_%7N?"YW7RJM0I5<%'EJOXTK\J]+W_``=CMOV,
M='U#7_VP?A39Z47&HS^+]*%N4^\K"[B.1]`"?PK]:O\`@Z`^+9\/_LT?#_P5
M'*%E\3^(7U&9`>6AM(2/R\RXC/U6OG__`(-W_P#@GQJWQ#^-5O\`''Q'ITUM
MX3\)>8GAXSQE1JVH,IC,T8/6*%6?YNAD*@9V-BG_`,'/7B^ZU/\`;(\#:(^X
M6>D>$1<P@]#)/=S!R/PAC'X5\UCL11QW%.'H4W?V*;?KV^6GXGTV!P];`<*X
MBO45G6:2]._SU/S7K]R/^#8_X3?\(M^QYXN\72)MF\7^)7BC/=H+2)8U_P#(
MCS5^&]?<_P#P1!_:)^+E[^UQ\._A)X<\;:QIO@"ZU6?5]3TF-8GADABB>>9=
MS(719"BJ0K#);U->YQM@:N*RFI"G)12]YWOM'6VE]=$>%P/CJ6%S:G.I%R<O
M=5N\M/N/Z"&0.I!&0>H]:_++]M/P]X[_`&7OVD-3TWPY;6\_A_5_^)GHXC\-
M6=V(HG;#PY\ACF-P5&3G:5/>OU-48&*\!_X*-_`;5?C5^S_<7'AJ>_M_%'AA
MSJ5@+2Y:![E0,30Y##[R<C/\2+7\X)ZG])'P=X9_:=_:`M%46'A^>9>,;/`%
MO@_BEL/YUWWAO]K/]JV)E-KX&O;@=O\`BB7C!_%0M>/^$?#7QSU%(VTKQ!XE
M16`*X\9Q1#'&.#<CVKT?PS\)/VL;M!]B\5>(D7L'\<VS#\OM#5H[`>HZ+^UO
M^UXY4-\)XKD?]-M$E@)_.<8_*NQT3]IW]K"\"^9\$="?U+W/V<_^/3FO-=#^
M!O[9K8:/QE/&B]Y_$%M,,>_RM7'>,_B'^U#%K!\'P^-8O%$VLQ&V_P")'?V$
M[-O!#(LBA9%8`'<R@;1DYXJ;`-^-W[3OQT_:7^,.F>%K3PK'HFH0RMIL>G1Z
M7'>6[3ASYDQGN(F"J`!EE.T*F>:^\OV5/V:+;]GKP-''>SVFL>*KY`VJZM'9
M0VYF;KY48C1<0J?N@\GDGD\8G[$O[)3_`+-'@02:UJU[K_C#58U.IWMQ=23I
M".HMX=Y.(U/4]6(R>,`>WU+8!1112`_-M_\`@V'^"DCEF\:_%(LQR2;VQ))]
M?^/:F2?\&P7P3="/^$T^*0R,<7MCQ_Y+5^D]%?2?ZX9S_P!!$OP_R/FO]3\F
M_P"@>/X_YF1X!\$:?\-/`NC>'=(A^SZ7H-C#IUG%_P`\X8HUC1?P517P?\5O
M^#<OX1?&+XI>)?%VJ^,OB7'J7BC5+G5KI(;NS$223RM(RH#;DA06(&23@#DU
M^@]%>9@<WQF#G*IA:CBY;M=3T\=E&#QD(T\334E'9/H?FRW_``;"?!,J<>-?
MBD#Z_;+'C_R6K[W^`7P5T7]G+X+>&?`OAV*6+1?"NGQ:=:>:0TLBHN#(Y``+
MNV68@#+,>*Z^BM,PSO'XZ*ABZKFEJK]R,OR/`X&3GA*2@WH['!_M%_LS^"?V
MK_AA>^#_`![H5MK^A7I$GE2DI);2@';-%(N&CD7)PRD'DCD$@_G)\3O^#6WP
MIJFJSS^#_BMXAT6T=B8[35=+BU`QCL/-1XB<>ZDU^J]%7EG$&89>G'"57%/I
MHU]S31GF?#^7Y@U+%TE)KKJG]ZLS\D_!W_!K%IT-XC^(?C)J-S;@_/%IN@1P
M.P]GDF<#_ODU]R_L7?\`!+OX/?L)(UWX+\//-XBEC,4VOZK+]KU*1#U57("Q
M*>ZQJH/?-?0]%;9AQ1FF-@Z>)K-Q?162?K9*_P`S++N%\KP,_:8:BE+N[M_)
MMNWR(=0T^#5[">UNH(KFUN8VBFAE0/'*C##*RG@@@D$'@@U^<?[1/_!M-\*/
MBAXHN]5\$>)O$'PZ-Y(TK:?'#'J.G0L23B)'*R(O/"^80.@`'%?I%17'EN<8
MW`2<\'4<&][;/U3T9V9EE&#Q\%#&4U-+:^Z]&M3\@+?_`(-7;C[?B7XUQ_9<
M]4\,?O,?0W.*]Y_9O_X-Q?@C\'=:M]3\6WFO_$N\MF#I;ZFR6NG$CH6@BY?Z
M.[*>X-?H-17JXGC/.:\'3G7=GV2C^*29Y.%X,R;#S]I3H*Z[MO\`!MHJZ)H=
MEX:TJWL-.M+:PL;.-8;>VMXEBA@C485$10`J@<``8%?.?_!07_@EC\./^"BM
MOI5SXK?6-&\0Z%$]O8:SI4J).D+'<89%=622/=\P!&02<$9.?I:BO!PF,KX:
MLJ^'DXS75'OXK!4,31="O!2@^CV/RIF_X-9?"#2YC^+_`(J5,]&T>V9L>F=X
MY_"O?_\`@GM_P1*\%_\`!/[XU2^.]/\`%WB+Q3K+:9-ID*WT$$,%NLK(SR*$
M&[=A-O7HQK[7HKV<5Q9FV)I2H5ZS<9:-62O]R/&PO">4X:K&O1HI2CJG=Z?>
MPI&`92"`01T]:6BOG3Z(_)']N']C"P^"?[1>IP+K?AGP_H'B%VU/25OQ<+LC
M=OWD0\N%P`DA(`SG:4XYK@M*_9L\/7<)D;XP_"NS91G:\U\&_P#285^E/_!1
M[]F:V_:*^`D\RK.-8\*,VJ63V\(FGD15/G0JI90V]!P,CYD6OR_TKPS\/]7B
M@AM_$'C>?4[MTB@MH?#D,AF=N%1<7622<``#FM(O0#3@^!K7&M6NF:)\2_".
MMZA?3+;6MKIMSJ+RW+L<!%46XR2?\3Q7Z-?L`?\`!/[3?V4/#[:SK$=EJ'CS
M4X]MS=1#=%IT9_Y80$@'TW/@%CQT`JC_`,$__P#@GSIG[-ML/%6M;]2\7ZA%
MB'[3"J'1HF7F)55G`E.<.X8_W1QG/U&!BI<NP!1114@%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`$9%?./[/'_``3[\&?"
M#]H+Q?XWA7[==-J3G1[62$+#H:R1I))Y?)W,6D8!B!M7@#J2447`^CJ***`"
*BBB@`HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
